[Federal Register Volume 64, Number 170 (Thursday, September 2, 1999)]
[Notices]
[Pages 48179-48180]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-22860]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[INFO-99-28]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call the CDC Reports
Clearance Officer on (404) 639-7090.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques for other
forms of information technology. Send comments to Seleda Perryman, CDC
Assistant Reports Clearance Officer, 1600 Clifton Road, MS-D24,
Atlanta, GA 30333. Written comments should be received within 60 days
of this notice.
Proposed Project
Translating Research Into Action for Diabetes (TRIAD)--New--The
National Center for Chronic Disease Prevention and Health Promotion
(NCCDPHP), Division of Diabetes Translation. Diabetes exerts a huge
public health burden, and there are several efficacious interventions
to combat the effects of this disease. Yet, the quality of care and
quality of life among people with diabetes remain sub-optimal in the
United States. The Centers for Disease Control and Prevention, Division
of Diabetes Translation, intends to conduct a multi-center study called
Translating Research Into Action for Diabetes (TRIAD). This study will
assess quality of diabetes care and identify effective means of
applying existing knowledge to improve care and quality of life. Data
provided from TRIAD will be critical to the Division of Diabetes
Translation's ongoing efforts to reduce the burden of diabetes.
Data will be collected through cooperative agreements with six
[[Page 48180]]
Managed Care Organizations (MCOs). Each MCO will provide data on
organization of care, details of diabetes interventions, and efforts to
improve diabetes care collected from interviews of health plan and
provider group directors. Each MCO will also provide data from random
samples of its diabetic members collected via computer-assisted
telephone interviews (CATIs). Information from plan members will
include demography, quality of diabetes care, quality of life,
satisfaction with care, diabetes severity and duration, and barriers to
care. Each MCO will collect data from directors and diabetic members at
baseline and after two years of follow-up. The total cost to
respondents is estimated at $1,620,000.
----------------------------------------------------------------------------------------------------------------
Number of Avg. burden of
Respondent Number of respondents responses/ response (In Total burden
respondent hrs.) (In hrs.)
----------------------------------------------------------------------------------------------------------------
Managed Care Organizations (MCOs)..... 6 MCOs--(each respondent 2 0.75 27,000
MCO will provide
information from an
average of 3,000 plan
members and directors).
-------------------------------------------------------------------------
Total............................. ........................ .............. .............. 27,000
----------------------------------------------------------------------------------------------------------------
Dated: August 24, 1999.
Nancy Cheal,
Acting Associate Director for Policy, Planning and Evaluation, Centers
for Disease Control and Prevention (CDC).
[FR Doc. 99-22860 Filed 9-1-99; 8:45 am]
BILLING CODE 4163-18-P
